A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

The Abu Dhabi Biobank campaign shed light on how cord blood can support the treatment of more than 80 serious diseases.

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, which results in rigid, malformed red blood cells with a sickle shape. This ...

The United Kingdom's Medicines and Healthcare Products Regulatory Agency strengthened its warnings on GLP-1 receptor agonists ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

There’s a Stem Cell Club at the University of Northern BC that is asking those between 17 and 35 years old to join the stem ...

Columnist Michelle Harlan, who's currently taking hydroxyurea to treat her sickle beta-zero thalassemia, considers some other ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...